Secretory phospholipase A₂ pathway during pediatric acute respiratory distress syndrome: a preliminary study.

Medicine and Dentistry

• Acute Respiratory Distress Syndrome 100%
• Pediatrics 100%
• Phospholipase A 100%
• Secretory Phospholipase A2 58%
• Tumor Necrosis Factor 41%
• Lung Lavage 25%
• Human Respiratory Syncytial Virus 25%
• Enzyme 25%
• Intensive Care 16%
• Intensive Care Unit 16%
• Cytokine 8%
• Pathophysiology 8%
• Oxygen Consumption 8%
• Silo-Filler's Disease 8%
• Disease Severity 8%
• Lung Injury 8%
• Mean Airway Pressure 8%
• Respiratory Syncytial Virus Infection 8%
• Bronchiolitis 8%
• Secretory Protein 8%

Nursing and Health Professions

• Adult Respiratory Distress Syndrome 100%
• Pediatrics 100%
• Phospholipase A 100%
• Secretory Phospholipase A2 58%
• Tumor Necrosis Factor 41%
• Enzyme 25%
• Lung Lavage 25%
• Pediatric Intensive Care Unit 16%
• Lung Disease 8%
• Pilot Study 8%
• Oxygenation 8%
• Disease Severity 8%
• Disease Control 8%
• Respiratory Syncytial Virus Infection 8%
• Pathophysiology 8%
• Protein Content 8%
• Oxygen Consumption 8%
• Cytokine 8%
• Lung Injury 8%
• Secretory Protein 8%
• Mean Airway Pressure 8%
• Viral Bronchiolitis 8%